Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma

NCT05005429 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Mesothelioma; Lung

Interventions

DRUG: Bintrafusp alfa

Sponsor

Fundación GECP